HCC patients with MCGs mutations had significantly higher expression levels of tumor-related genes, including MET, TP53, ARID1A, and TTN (Figure 1E), while no significant differences were found among patients divided by SCNA status (Figure 1F). Here, MET is linked to neoplasm.